Froceth logo
  • HOME

  • ABOUT US

  • SERVICES

    • MANUFACTURING OF MEDICINAL PRODUCTS
    • TISSUE BANK
    • SCIENTIFIC RESEARCH LABORATORY
    • CLINICAL TRIALS
  • MEDICINAL PRODUCTS

    • CANCER IMMUNOTHERAPY
    • TISSUE REGENERATION
    • MULTIPLE SCLEROSIS THERAPY
  • NEWS

    • ALL NEWS
  • EU PROJECTS

  • CONTACTS

  • More...

    Use tab to navigate through the menu items.
    English
    English
    Lithuanian
    • All news
    Effectiveness of anti-cancer vaccination in treating metastasis in murine models
    • Jun 15, 2020

    Effectiveness of anti-cancer vaccination in treating metastasis in murine models

    Our team’s researchers published a scientific article for Spandidos Publications journal Oncology Letters on the effectiveness of...
    Privacy policy!
    • Apr 9, 2020

    Privacy policy!

    We recognize that the information we collect from patients and doctors is often of a highly sensitive nature. Because of that, the...
    Lithuanians develop unique cancer immunotherapy products
    • Apr 9, 2020

    Lithuanians develop unique cancer immunotherapy products

    Lithuanian scientists started scientific research planning to develop world-unique cancer immunotherapy products. Especially advanced...
    The beginning of a new era of cancer treatment
    • Dec 5, 2017

    The beginning of a new era of cancer treatment

    Froceth, JSC, a biotechnology company founded by Lithuanian scientists three years ago, is the only one in the country that manufactures...

    DETAILS

    Froceth, JSC

    Mokslininku str. 6A,  08412 Vilnius, Lithuania

    Company code 302726732

    VAT code LT100008547516

    ​

    info@froceth.lt

    +370 648 37 591

    ©2022 FROCETH, JSC | Privacy policy!